Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
Clinical efficacy: Head-to-head comparison While both SLU-PP-332 and 5-amino-1mq show promise in various therapeutic areas, their clinical efficacy can differ significantly
Each order is carefully packed to protect against temperature fluctuations, moisture exposure, and physical damage during transit
AOD-9604s lack of IGF-1 impact may make it more appropriate for individuals with these concerns, though individual medical evaluation remains essential
US$ 26.35
US$ 29.75
US$ 23.39
